IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cell Therapeutics Inc

Q1 2016 vs Q2 2016

Comparing institutional holders between quarters

Quarters

Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Vantage Investment Advisors, LLC
UNCHANGED
Shares800 from 800
Change0 (0%)
Value$0 ($0)
Filed 2016-08-12
Status
Vantage Investment Advisors, LLC
UNCHANGED80080000%$0$0$02016-08-12
Showing 1 of 1 institutions